SNY - Sanofi a beneficiary of Alnylam's data on heart drug Amvuttra
2024-06-24 13:25:16 ET
More on Sanofi
- Sanofi's Immunology Business Is Doing A Lot Of Heavy Lifting
- Sanofi: A Leader In Life-Saving Vaccines And Treatments
- Sanofi Q1: Wait And See For Now (Downgrade)
- Innate falls on updated phase 1/2 data on blood cancer asset teamed with Sanofi
- CDC 'preparing for the possibility' bird flu could spread more easily